Previous 10 | Next 10 |
Healthcare lagged the broader market last year, but that can change this year. A cyclical upturn as the pandemic abates and pent-up demand can boost healthcare. Best positioned are industry groups within healthcare that can achieve secular growth beyond the cyclical rise. Biot...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the fourth quarter and fiscal year ended January 1, 2021 on Wedn...
Tuesday is shaping up to be a good day for shareholders of STAAR Surgical (NASDAQ: STAA) , which manufactures implantable lenses, and Prestige Consumer Healthcare (NYSE: PBH) , which markets over-the-counter (OTC) healthcare products. As of 1:30 p.m. EST today, STAAR Surgica...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the appointments of Elizabeth Yeu, M.D., Partner, Virginia Eye Consultants, and K. Peony Yu, M.D., retired Chief Medica...
Staar Surgical Set to Join S&P MidCap 400; Prestige Consumer Healthcare & Bridge Bancorp to Join S&P SmallCap 600 Staar Surgical Set to Join S&P MidCap 400; Prestige Consumer Healthcare & Bridge Bancorp to Join S&P SmallCap 600 PR Newswire N...
Staar Surgical (STAA) is up 5.8% after hours following news that it's moving into the S&P MidCap 400 index. It's replacing Prestige Consumer Healthcare (PBH), which is going to the SmallCap 600 as more representative of that space. And there PBH is replacing Foundation Building Materials ...
Net Sales Approximately $46 Million in Fourth Quarter and $163 Million for Full Year STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided preliminary results for...
STAAR Surgical manufactures and sells implantable collamer lenses (ICLs) for patients suffering from myopia or presbyopia. The company only makes ~3.5% in the US market and its largest market shares are in APAC - but STAAR is chasing an approval for its latest products in US. STAA...
Image source: The Motley Fool. Staar Surgical Co (NASDAQ: STAA) Q3 2020 Earnings Call Nov 4, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Staar Surgical Co (STAA) Q3 2020 Earnings Call Transcript
STAAR Surgical Company (STAA) Q3 2020 Earnings Conference Call November 4, 2020 4:30 p.m. ET Company Participants Brian Moore - VP, Investor, Media Relations and Corporate Development Caren Mason - President and CEO Patrick Williams - CFO Conference Call Participants Anthony Petrone - Jefferi...
News, Short Squeeze, Breakout and More Instantly...
STAAR Surgical Company Company Name:
STAA Stock Symbol:
NASDAQ Market:
STAAR Surgical Company Website:
2024-07-14 17:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with Patrick F. Will...
2024-05-24 07:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...